Product Information
PALIPERIDONE ER 3 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.9527 per EA under NDC 43975035003. Its NADAC has been published 321 times since May 6, 2020.
Strength
3 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
43975035003
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PALIPERIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA204452On Market Since
11/27/2019
Pharmacological Classes
Price Statistics
The NADAC for PALIPERIDONE ER 3 MG TABLET has been published 321 times since May 6, 2020, and over the history we have for it it has declined 88.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9527 per EA |
|---|---|
| All-time high | $9.3768 (Jun 10, 2020) |
| All-time low | $0.9527 (Jun 17, 2026) |
| 52-week high | $1.2758 |
| 52-week low | $0.9527 |
| Median price | $2.0481 |
| Average price | $3.5356 |
| Largest weekly change | +62.1% (Jul 21, 2021) |
| Weeks tracked | 321 |
| Tracking since | May 6, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PALIPERIDONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PALIPERIDONE ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 3 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.9527 per EA (NDC 43975035003), effective Jun 24, 2026.
How has the price of PALIPERIDONE ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for PALIPERIDONE ER 3 MG TABLET has declined 88.6%. It has been tracked across 321 weekly CMS publications since May 6, 2020.
What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 3 MG TABLET?
Since May 6, 2020, the NADAC for PALIPERIDONE ER 3 MG TABLET has ranged from a low of $0.9527 (Jun 17, 2026) to a high of $9.3768 (Jun 10, 2020), with a median of $2.0481 per EA.
Are there cheaper alternatives to PALIPERIDONE ER 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PALIPERIDONE ER 3 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PALIPERIDONE ER 3 MG TABLET?
PALIPERIDONE ER 3 MG TABLET (NDC 43975035003) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification